Michael Feld compensation by year
BECTON DICKINSON Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $775,000 |
| Bonus | $0 |
| Stock awards | $1,641,596 |
| Option awards | $544,118 |
| Non-equity incentive | $533,588 |
| Pension and deferred compensation | $0 |
| All other | $602,054 |
| Total | $4,096,356 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BECTON DICKINSON & CO DEF 14A filed December 18, 2025, accession 0001628280-25-057846, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 10,170 | $1,903,519 | — |
| RSU | 6,976 | $1,305,698 | — |
| SAR | 10,004 | — | $224.25 |
Per the Outstanding Equity Awards at Fiscal Year-End table in BECTON DICKINSON & CO's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
10 Form 4 lines since the FY2025 proxy (filed December 18, 2025)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-26 | Sale | 10b5-1 | 165 | $188.49 | 19,720 |
| 2026-08-20 | Tax withholding | — | 1,049 | $0.00 | 19,885 |
| 2026-07-27 | Sale | 10b5-1 | 75 | $157.13 | 20,934 |
| 2026-06-26 | Sale | 10b5-1 | 75 | $152.80 | 21,009 |
| 2026-05-26 | Sale | 10b5-1 | 75 | $147.35 | 21,084 |
| 2026-04-27 | Sale | 10b5-1 | 74 | $151.94 | 21,159 |
| 2026-03-26 | Sale | 10b5-1 | 75 | $156.83 | 21,233 |
| 2026-02-26 | Sale | 10b5-1 | 75 | $181.84 | 21,308 |
The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
BECTON DICKINSON’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Thomas Polen | Chairman, Chief Executive Officer and President | $17,129,140 |
| Christopher DelOrefice | Executive Vice President and Chief Financial Officer | $5,877,164 |
| Michael Feld · this page | Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment | $4,096,356 |
| Michael Garrison | Executive Vice President and President, Medical Essentials and BioPharma Systems Segments | $3,649,040 |
| Richard Byrd | Executive Vice President and President, Interventional Segment | $3,399,056 |
The full BECTON DICKINSON compensation record
free company briefThis page is one person within BECTON DICKINSON's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BECTON DICKINSON's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BECTON DICKINSON's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat